We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City.
- Authors
Cowman, Kelsie; Guo, Yi; Pirofski, Liise-anne; Wong, David; Bao, Hongkai; Chen, Victor; Hopkins, Una; Andrews, Erin; Hamel, Joseph; Keller, Marla; Bellin, Eran; Thota, Raja; Davis, Patricia; Rodriguez, Edwin Torres; Suthar, Pooja; Allen, Lauren; Rossi, James; Haviland, Adam; Orner, Erika; Szymczak, Wendy
- Abstract
We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City.
- Subjects
NEW York (N.Y.); COVID-19; MONOCLONAL antibodies; SARS-CoV-2; HOSPITAL care; SYNDROMES
- Publication
Open Forum Infectious Diseases, 2021, Vol 8, Issue 8, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofab313